DSpace Repository

International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012

Show simple item record

dc.contributor.author Leblebicioglu, H.
dc.contributor.author Erben, N.
dc.contributor.author Rosenthal, V.D.
dc.contributor.author Atasay, B.
dc.contributor.author Erbay, A.
dc.contributor.author Unal, S.
dc.contributor.author Senol, G.
dc.date.accessioned 2019-08-16T12:29:20Z
dc.date.available 2019-08-16T12:29:20Z
dc.date.issued 2014
dc.identifier.issn 1476-0711
dc.identifier.uri https://hdl.handle.net/11499/7342
dc.identifier.uri https://doi.org/10.1186/s12941-014-0051-3
dc.description.abstract Background: Device-associated healthcare-acquired infections (DA-HAI) pose a threat to patient safety, particularly in the intensive care unit (ICU). We report the results of the International Infection Control Consortium (INICC) study conducted in Turkey from August 2003 through October 2012. Methods: A DA-HAI surveillance study in 63 adult, paediatric ICUs and neonatal ICUs (NICUs) from 29 hospitals, in 19 cities using the methods and definitions of the U.S. NHSN and INICC methods. Results: We collected prospective data from 94,498 ICU patients for 647,316 bed days. Pooled DA-HAI rates for adult and paediatric ICUs were 11.1 central line-associated bloodstream infections (CLABSIs) per 1000 central line (CL)-days, 21.4 ventilator-associated pneumonias (VAPs) per 1000 mechanical ventilator (MV)-days and 7.5 catheter-associated urinary tract infections (CAUTIs) per 1000 urinary catheter-days. Pooled DA-HAI rates for NICUs were 30 CLABSIs per 1000 CL-days, and 15.8 VAPs per 1000 MV-days. Extra length of stay (LOS) in adult and paediatric ICUs was 19.4 for CLABSI, 8.7 for VAP and 10.1 for CAUTI. Extra LOS in NICUs was 13.1 for patients with CLABSI and 16.2 for patients with VAP. Extra crude mortality was 12% for CLABSI, 19.4% for VAP and 10.5% for CAUTI in ICUs, and 15.4% for CLABSI and 10.5% for VAP in NICUs. Pooled device use (DU) ratios for adult and paediatric ICUs were 0.54 for MV, 0.65 for CL and 0.88 for UC, and 0.12 for MV, and 0.09 for CL in NICUs. The CLABSI rate was 8.5 per 1,000 CL days in the Medical Surgical ICUs included in this study, which is higher than the INICC report rate of 4.9, and more than eight times higher than the NHSN rate of 0.9. Similarly, the VAP and CAUTI rates were higher compared with U.S. NHSN (22.3 vs. 1.1 for VAP; 7.9 vs. 1.2 for CAUTI) and with the INICC report (22.3 vs. 16.5 in VAP; 7.9 vs. 5.3 in CAUTI). Conclusions: DA-HAI rates and DU ratios in our ICUs were higher than those reported in the INICC global report and in the US NHSN report. © 2014 Leblebicioglu et al. en_US
dc.language.iso en en_US
dc.publisher BioMed Central Ltd. en_US
dc.relation.ispartof Annals of Clinical Microbiology and Antimicrobials en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Antibiotic resistance en_US
dc.subject Bloodstream infection en_US
dc.subject Catheter-associated urinary tract infection en_US
dc.subject Central line-associated bloodstream infections en_US
dc.subject Device-associated infection en_US
dc.subject Healthcare-associated infection en_US
dc.subject Hospital infection en_US
dc.subject INICC en_US
dc.subject International Nosocomial Infection Consortium en_US
dc.subject Network en_US
dc.subject Nosocomial infection en_US
dc.subject Turkey en_US
dc.subject Urinary tract infection en_US
dc.subject Ventilator-associated pneumonia en_US
dc.subject adult en_US
dc.subject Article en_US
dc.subject catheter infection en_US
dc.subject central venous catheter en_US
dc.subject critically ill patient en_US
dc.subject device infection en_US
dc.subject disease surveillance en_US
dc.subject healthcare associated infection en_US
dc.subject human en_US
dc.subject infection control en_US
dc.subject infection rate en_US
dc.subject intensive care en_US
dc.subject intensive care unit en_US
dc.subject length of stay en_US
dc.subject major clinical study en_US
dc.subject mechanical ventilator en_US
dc.subject mortality en_US
dc.subject newborn en_US
dc.subject prospective study en_US
dc.subject Turkey (republic) en_US
dc.subject urinary catheter en_US
dc.subject urinary tract infection en_US
dc.subject ventilator associated pneumonia en_US
dc.subject adolescent en_US
dc.subject Catheter-Related Infections en_US
dc.subject child en_US
dc.subject cohort analysis en_US
dc.subject cross infection en_US
dc.subject devices en_US
dc.subject female en_US
dc.subject infant en_US
dc.subject male en_US
dc.subject Pneumonia, Ventilator-Associated en_US
dc.subject preschool child en_US
dc.subject prevalence en_US
dc.subject Adolescent en_US
dc.subject Adult en_US
dc.subject Child en_US
dc.subject Child, Preschool en_US
dc.subject Cohort Studies en_US
dc.subject Cross Infection en_US
dc.subject Equipment and Supplies en_US
dc.subject Female en_US
dc.subject Humans en_US
dc.subject Infant en_US
dc.subject Infant, Newborn en_US
dc.subject Male en_US
dc.subject Prevalence en_US
dc.subject Prospective Studies en_US
dc.title International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012 en_US
dc.type Article en_US
dc.identifier.volume 13 en_US
dc.identifier.issue 1 en_US
dc.identifier.doi 10.1186/s12941-014-0051-3
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.identifier.pmid 25403704 en_US
dc.identifier.scopus 2-s2.0-84924404357 en_US
dc.identifier.wos WOS:000346433300001 en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record